Predicting the oral pharmacokinetic profiles of multiple-unit (pellet) dosage forms using a modeling and simulation approach coupled with biorelevant dissolution testing: case example diclofenac sodium.
The objective of this research was to characterize the dissolution profile of a poorly soluble drug, diclofenac, from a commercially available multiple-unit enteric coated dosage form, Diclo-Puren® capsules, and to develop a predictive model for its oral pharmacokinetic profile. The paddle method was used to obtain the dissolution profiles of this dosage form in biorelevant media, with the exposure to simulated gastric conditions being varied in order to simulate the gastric emptying behavior of pellets. A modified Noyes-Whitney theory was subsequently fitted to the dissolution data. A physiologically-based pharmacokinetic (PBPK) model for multiple-unit dosage forms was designed using STELLA® software and coupled with the biorelevant dissolution profiles in order to simulate the plasma concentration profiles of diclofenac from Diclo-Puren® capsule in both the fasted and fed state in humans. Gastric emptying kinetics relevant to multiple-units pellets were incorporated into the PBPK model by setting up a virtual patient population to account for physiological variations in emptying kinetics. Using in vitro biorelevant dissolution coupled with in silico PBPK modeling and simulation it was possible to predict the plasma profile of this multiple-unit formulation of diclofenac after oral administration in both the fasted and fed state. This approach might be useful to predict variability in the plasma profiles for other drugs housed in multiple-unit dosage forms.
Institute of Pharmaceutical Technology, Goethe University, Frankfurt am Main, Germany.
Atsushi
A
Kambayashi
SocraTec R&D GmbH, Oberursel, Germany.
Henning
H
Blume
Institute of Pharmaceutical Technology, Goethe University, Frankfurt am Main, Germany. Electronic address: dressman@em.uni-frankfurt.de.
Jennifer B
JB
Dressman
D000284:Administration, Oral; D002214:Capsules; D003198:Computer Simulation; D004008:Diclofenac / Q000008:administration & dosage* / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics*; D005215:Fasting / Q000097:blood; D005746:Gastric Emptying; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008954:Models, Biological; D019518:Postprandial Period; D012995:Solubility; D013678:Technology, Pharmaceutical / Q000379:methods*
D002214:Capsules; D004008:Diclofenac
Biorelevant media; Diclofenac; Enteric coated pellet; Modeling and simulation; Multiple units dosage form; Oral administration; Pharmacokinetics